HTI-286, a synthetic analog of the antimitotic natural product hemiasterlin

Anticancer Agents from Natural Products

Volumn , Issue , 2005, Pages 267-280

  Andersen, Raymond J ^a   Roberge, Michel ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH;

ANTICANCER DRUG; CLINICAL TRIAL; MITOTIC ARREST; MULTIDRUG RESISTANTS; NATURAL PRODUCTS; SMALL CELL LUNG CANCERS; SYNTHETIC ANALOGS; TUMOR XENOGRAFT MODELS;

TUMORS;

EID: 34547786929     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (30)

1. Margaret and Charles Juravinski Cancer Centre. Cancer Services. Available at: http://www.hrcc.on.ca/ActiveTrials.asp.
2. Talpir, R., et al., Hemiasterlin and geodiamolide TA: two new cytotoxic peptides from the marine sponge Hemiasterella minor (Kirkpatrick), Tetrahedron Lett., 35, 4453, 1994
3. Crews, P., et al., A highly methylated cytotoxic tripeptide from the marine sponge Auletta cf constricta, J. Org. Chem., 59, 2932, 1994.
4. Matsunaga, S., Fusetani, N., and Konosu, S., Bioactive metabolites VI. Structure elucidation of discodermin A, an antimicrobial peptide from the marine sponge Discodermia kiiensis, Tetrahedron Lett., 25, 5165, 1984.
5. Kaneda, M., Studies on the Bottromycins. I. proton and carbon-13 NMR assignments of bottromycin A2, the main component of the complex, J. Antibiot., 45, 792, 1992.
6. Coleman, J. E., et al., Cytotoxic peptides from the marine sponge Cymbastela sp, Tetrahedron, 51, 10653, 1995.
7. Coleman, J. E., et al., Hemiasterlin methyl ester, Acta Crystal., 52, 1525, 1996.
8. Gamble, W. R., et al., Cytotoxic and tubulin-interactive hemiasterlins from Auletta sp. and Siphonochalina spp. sponges, Bioorg. Med. Chem., 7, 1611, 1999.
9. Chevallier, C., et al., A new cytotoxic and tubulin-interactive milnamide derivative from a marine sponge Cymbastela sp., Org. Lett., 5, 3737, 2003.
10. Hooper, J. N. A. and van Soest, R. W. M., Systema Porifera, a Guide to the Classification of Sponges, Kluwer Academic/Plenum, New York, 2002.
11. Kunze, B., et al., Chondramines A-D, new antifungal and cytostatic depsipeptides from Chondromyces crocatus (Myxobacteria). Production, physico-chemical and biological properties, J. Antibiot., 48, 1262, 1995.
12. Anderson, H. J., et al., Cytotoxic peptides hemiasterlin, hemiasterlin A and hemiasterlin B induce mitotic arrest and abnormal spindle formation, Cancer Chemother. Pharmacol., 39, 223, 1997.
13. Personal communication from Peter Lassota.
14. Bai, R., et al., Interactions of the sponge-derived antimitotic tripeptide heniasterlin with tubulin: comparison with dolastatin 10 and cryptophycin 1, Biochemistry, 38, 14302, 1999.
15. Hamel, E., Interactions of antimitotic peptides and depsipeptides with tubulin, Biopolymers, 66, 142, 2002.
16. Boukari, H., Nossal, R., and Sackett, D. L., Stability of drug-induced tubulin rings by fluorescence correlation spectroscopy, Biochemistry, 42, 1292, 2003.
17. Ireland, C. M., et al., Anticancer agents from unique natural products sources, Pharmaceutical Biol., in press, 2004.
18. Andersen, R. J., et al., Total synthesis of (-)-hemiasterlin, a structurally novel tripeptide that exhibits potent cytotoxic activity, Tetrahedron Lett., 38, 317, 1997.
19. Nieman, J., et al., Synthesis and antimitotic/cytotoxic activity of hemiasterlin analogs, J. Nat. Prod., 66, 183, 2003.
20. Vedejs, E. and Kongkittingam, C., A total synthesis of (-)-hemiasterlin using N-Bts methodology, J. Org. Chem., 66, 7355, 2001.
21. Reddy, R., et al., Asymmetric synthesis of the highly methylated tryptophan portion of the hemiasterlin tripeptides, Org. Lett., 4, 695, 2002.
22. Roberge, M., et al., Cell-based screen for antimitotic agents and identification of analogues of rhizoxin, eleutherobin and paclitaxel in natural extracts, Cancer Res., 60, 5052, 2000.
23. Andersen, R. J., et al. WO Patent 99/32509, 1999.
24. Loganzo, F., et al., HTI-286, a synthetic analog of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo, Cancer Res., 63, 1838, 2003.
25. Nunes, M., et al., Two photoaffinity analogs of HTI-286, a synthetic analog of hemiasterlin, interact with alpha-tubulin, Eur. J. Cancer, 38, S119, 2002.
26. Wang, C. P., et al., In vitro and in vivo metabolism of HTI-286, an antimicrotubule anticancer agent, Drug Metabol. Rev., 35 Suppl. 2, 42, 2003.
27. Ratain, M. J., et al., Phase 1 and pharmacological study of HTI-286, a novel antimicrotubule agent: correlation of neutropenia with time above a threshold serum concentration, Proc. Am. Soc. Clin. Oncol., 22, 129, 2003.
28. Newman, D. J., Cragg, G. M., and Snader, K. M., Natural products as sources of new drugs over the period 1981–2002, J. Nat. Prod., 66, 1022, 2003.
29. Andersen, R. J. and Williams, D. E., in Chemistry in the Marine Environment, Vol. 13, R. E. Hester and R. M. Harrison, Eds., The Royal Society of Chemistry, Cambridge, 2000, 55.
30. Blunt, J., et al., Marine natural products, Nat. Prod. Rep., 20, 1, 2003.